Chair(s): Michael Kreuter, Marlies S. Wijsenbeek
Session type: Symposium
Anna Podolanczuk
Session content
Elizabeth Robertson
Replay
Phil Molyneaux
Replay
Slides
Diagnostic challenges and biomarkers to profile progression. Time is gold
Anna Podolanczuk
Replay
Slides
Moises Eduardo Selman Lama
Replay
Elisabeth Bendstrup
Replay
Slides
Discussion and Q&A
Session aims
to describe the magnitude of the problem of progressive pulmonary fibrosis (PPF); to discuss the diagnostic tools to detect or predict PPF; to explore some of the putative pathogenic mechanisms that may be involved in the progression of fibrotic lung disorder; to discuss the therapeutic approach, covering immunosuppression and antifibrotic drugs, antifibrotic drugs alone, nonpharmacological support, and when to start and stop this all.